HIMS & Hers Health (NYSE: HIMS) financial statements
The consolidated income statement, balance sheet and cash flow statement of HIMS & Hers Health for its last 7 fiscal years, as filed with the regulator, in millions of US dollars. At the end of fiscal 2025 it had $2,155m in total assets and $540.9m in equity.
Income statement
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2,348m | $1,477m | $872.0m | $526.9m | $271.9m | $148.8m | $82.6m |
| Cost of sales | $614.3m | $303.4m | $157.1m | $118.2m | $67.4m | $39.3m | $38.0m |
| Gross profit | $1,733m | $1,173m | $714.9m | $408.7m | $204.5m | $109.5m | $44.6m |
| Operating profit | $105.6m | $61.9m | −$29.5m | −$68.7m | −$115.0m | −$15.1m | −$74.4m |
| Finance costs | — | — | — | — | $0.0m | $0.0m | $0.4m |
| Profit before tax | $123.9m | $71.7m | −$21.6m | −$65.7m | −$110.8m | −$18.0m | −$72.0m |
| Income tax | $4.4m | $54.3m | $2.0m | $0.0m | $3.1m | $0.1m | $0.1m |
| Net profit | $128.4m | $126.0m | −$23.5m | −$65.7m | −$107.7m | −$18.1m | −$72.1m |
| Earnings per share | $0.57 | $0.58 | −$0.11 | −$0.32 | −$0.58 | — | — |
| Diluted earnings per share | $0.51 | $0.53 | −$0.11 | −$0.32 | −$0.58 | — | — |
| Depreciation and amortisation | $54.5m | $17.1m | $9.5m | $7.5m | $4.1m | $1.1m | $0.3m |
Balance sheet
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Total assets | $2,155m | $707.5m | $441.2m | $366.3m | $420.6m | $118.7m | $204.8m |
| Current assets | $767.6m | $395.8m | $265.1m | $216.6m | $269.9m | $113.1m | $1.7m |
| Inventories | $80.1m | $64.4m | $22.5m | $21.6m | $13.6m | $3.5m | $4.2m |
| Property, plant and equipment | — | — | — | $3.0m | $2.2m | $1.7m | — |
| Goodwill | $278.3m | $112.7m | $110.9m | $110.9m | $110.9m | $0.0m | — |
| Cash | $228.6m | $220.6m | $96.7m | $46.8m | $71.8m | $27.3m | $1.5m |
| Total liabilities | $1,614m | $230.8m | $97.2m | $54.6m | $86.0m | $15.6m | $8.2m |
| Current liabilities | $404.4m | $221.4m | $88.5m | $47.9m | $79.2m | $15.2m | $1.0m |
| Equity | $540.9m | $476.7m | $344.0m | $311.7m | $334.6m | −$146.9m | −$139.8m |
| Equity including minorities | $540.9m | $476.7m | $344.0m | $311.7m | $334.6m | −$146.9m | −$139.8m |
Cash flow statement
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $300.0m | $251.1m | $73.5m | −$26.5m | −$34.4m | −$2.5m | −$74.9m |
| Investing cash flow | −$1,025m | −$19.0m | −$12.1m | $34.7m | −$156.3m | −$39.7m | −$39.3m |
| Financing cash flow | $729.6m | −$107.8m | −$11.5m | −$33.1m | $235.0m | $47.7m | $95.3m |
| Capital expenditure | −$242.6m | −$52.8m | −$26.5m | −$7.2m | — | — | — |
Where each figure comes from
From the annual report (Form 10-K) that HIMS & Hers Health files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the HIMS & Hers Health page.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.